Wound News and Research

RSS

TxCell to present at upcoming US and French investment conferences

Damian Marron, CEO, TxCell, will present at the Alliance for Regenerative Medicine's 3rd Annual Regen Med Investor Day, New York, March 25, 2015. In addition, Damian Marron will also participate at the Portzamparc PEA-PME Forum, Paris, April 1, 2015.

24 Mar 2015

DNA sequence determines flexibility, stability of DNA package inside microscopic cell

To pack two meters of DNA into a microscopic cell, the string of genetic information must be wound extremely carefully into chromosomes. Surprisingly the DNA's sequence causes it to be coiled and uncoiled much like a yoyo, scientists reported in Cell.

18 Mar 2015

TCC-EZ Casting System dramatically increases healing process of diabetic foot ulcers

Diabetics once facing the prospect of amputation to their lower limbs due to the effects of foot ulcers are now back on their feet thanks to a new technology.

18 Mar 2015

New vaccine for post exposure treatment of rabies infection enters human clinical trial

Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on the research, development, manufacturing, sales and marketing of vaccine products, announced that a new vaccine for the post exposure treatment of the rabies infection was entering human clinical trial after a six-year long collaboration with a number of research institutes worldwide.

16 Mar 2015

Study sheds light on cell migration mechanisms involved in wound-healing process

Researchers at the University of Arizona have discovered what causes and regulates collective cell migration, one of the most universal but least understood biological processes in all living organisms.

16 Mar 2015

Cancer drug promotes neuronal regeneration after spinal cord injury

Damage to the spinal cord rarely heals because the injured nerve cells fail to regenerate. The regrowth of their long nerve fibers is hindered by scar tissue and molecular processes inside the nerves.

13 Mar 2015

New injectable polymer could strengthen blood clots

Most military battlefield casualties die before ever reaching a surgical hospital. Of those soldiers who might potentially survive, most die from uncontrolled bleeding.

11 Mar 2015

TWi Biotechnology obtains Rare Disease Drug designation in Taiwan for use of AC-203 to treat EBS

TWi Pharmaceuticals, Inc. today announced that its fully owned subsidiary, TWi Biotechnology, Inc., has received the designation of Rare Disease Drug by Taiwan FDA for use of AC-203 to treat Epidermolysis Bullosa Simplex (EBS), and is eligible for applying for coverage under National Health Insurance Administration.

10 Mar 2015

New conference to discuss ways of abolishing female genital mutilation in the UK

'We believe that education is the way forward to eradicate FGM. Therefore, in this symposium we are also launching an educational package for both professionals and communities alike'- Sadiyo Siad, FGM survivor, activist and campaigner.

4 Mar 2015

Novel drug mechanism shows promise against glioma cells

Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells - responsible for a usually fatal type of brain cancer - and could be applicable to other highly aggressive cancers.

4 Mar 2015

Regenicin receives final payment to conclude Asset Purchase Agreement with Amarantus

Regenicin, Inc. a biotechnology company specializing in the development of and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, announced today that it has received the final payment to conclude The Asset Purchase Agreement with Amarantus Bioscience Holdings, Inc.

3 Mar 2015

New insights into the use, outcomes of gluteoplasty and vaginal labiaplasty procedures

Two of the fastest-growing plastic surgery procedures are gluteoplasty or "butt augmentation," to improve the appearance of the buttocks; and labiaplasty to address cosmetic and functional concerns with the vagina.

3 Mar 2015

Prime Healthcare acquires two hospitals from subsidiaries of Community Health Systems

Prime Healthcare announced today that it has completed its acquisition of two hospitals from subsidiaries of Community Health Systems: Dallas Regional Medical Center in Mesquite, Texas and Riverview Regional Medical Center in Gadsden, Alabama, as well as related outpatient services.

2 Mar 2015

Covalon reports financial results for first quarter 2014

Covalon Technologies Ltd., an advanced medical technologies company, today announced financial results for its first quarter ended December 31, 2014.

28 Feb 2015

MiMedx Group reports record revenue of $118.2 million for full year 2014

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the fourth quarter and full year ended December 31, 2014.

26 Feb 2015

Frailty assessment test can accurately predict complications after major operation

Frailty has been used to predict how well a patient may recover from a major operation. Because frailty assessments are not routinely utilized in busy surgical practices, surgeons at Emory University School of Medicine in Atlanta have discovered that a short, approximately one-minute assessment can accurately determine how likely a patient is to have complications after an operation.

26 Feb 2015

Novel technology could improve diagnosis of peripheral arterial disease

Approximately 8 to 12 million people in the United States alone are suffering from peripheral arterial disease (PAD), a common vascular problem that is caused by narrowing of the arteries as a result of plaque buildup. The plaque accumulation leads to an insufficient blood flow to the body's extremities and increases a person's risk for heart attack and stroke by up to six times. PAD is also one of the most serious complications of diabetes.

26 Feb 2015

Psoriasis management: an interview with Dr Sandy McBride

A major challenge around treating psoriasis is communication - psoriasis can flare and resolve in between appointments so it can be difficult to express and describe the life impact of these flares and recall possible triggers and response to treatments. People with psoriasis can also find it very difficult to talk about their emotions – something known as alexithymia – again making it difficult for clinicians to fully appreciate the impact of psoriasis.

25 Feb 2015

Kuros Biosurgery granted U.S. patent for synthetic hydrogel technology

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for sealant, orthobiologic and surgical wound indications, announced today that its patent application U.S.S.N 12/102,157 will issue today and has been assigned U.S. Patent No. 8,961,947.

24 Feb 2015

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores).

23 Feb 2015

Wound News and Research

TxCell to present at upcoming US and French investment conferences

DNA sequence determines flexibility, stability of DNA package inside microscopic cell

TCC-EZ Casting System dramatically increases healing process of diabetic foot ulcers

New vaccine for post exposure treatment of rabies infection enters human clinical trial

Study sheds light on cell migration mechanisms involved in wound-healing process

Cancer drug promotes neuronal regeneration after spinal cord injury

New injectable polymer could strengthen blood clots

TWi Biotechnology obtains Rare Disease Drug designation in Taiwan for use of AC-203 to treat EBS

New conference to discuss ways of abolishing female genital mutilation in the UK

Novel drug mechanism shows promise against glioma cells

Regenicin receives final payment to conclude Asset Purchase Agreement with Amarantus

New insights into the use, outcomes of gluteoplasty and vaginal labiaplasty procedures

Prime Healthcare acquires two hospitals from subsidiaries of Community Health Systems

Covalon reports financial results for first quarter 2014

MiMedx Group reports record revenue of $118.2 million for full year 2014

Frailty assessment test can accurately predict complications after major operation

Novel technology could improve diagnosis of peripheral arterial disease

Psoriasis management: an interview with Dr Sandy McBride

Kuros Biosurgery granted U.S. patent for synthetic hydrogel technology

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News